Description:

Medicamentos exclusivos: emtricitabina/tenofovir/elvitegravir/cobicistat 150/150/200/10 mg (30 comprimidos); sofosbuvir/velpatasvir 400/100 (28 comprimidos).

Emtricitabina/tenofovir/elvitegravir/cobicistat 150/150/200/10 mg (30 comprimidos)

Emtricitabina/tenofovir/elvitegravir/cobicistat 150/150/200/10 mg (30 comprimidos).

Awarded to:

Emtricitabina/tenofovir/elvitegravir/cobicistat 150/150/200/10 mg (30 comprimidos)

Gilead Sciences, S. L. U., Madrid (ES)

Download full details as .pdf

The Buyer:

Área Sanitaria IV - Hospital Universitario Central de Asturias

CPV Code(s):

33600000 - Pharmaceutical products